Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy (Q47677806)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

B-cell chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

M Hoogendoorn

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

J Olde Wolbers

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

W M Smit

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

M R Schaafsma

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

R M Y Barge

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

R Willemze

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

J H F Falkenburg

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

18

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

1278-1287

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403358

0 references

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Monoclonal antibody therapy of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

B7-mediated costimulation and the immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Growing human B lymphocytes in the CD40 system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

21 January 2018

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403358

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403358

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15116118

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47677806&oldid=2165195927"